BiotechTube
Home/NanoViricides/Anil R. Diwan
AR

Anil R. Diwan

Executive Chairman, President

NanoViricides

Therapeutic Areas

Infectious DiseaseVirology

NanoViricides Pipeline

DrugIndicationPhase
NV-387MPox / SmallpoxPhase II
NV-HHV-1 / HerpeCideShingles (VZV) - TopicalPhase I/II (implied)
HerpeCide VariantsHSV-1 (Cold Sores)Preclinical
HIVCideHIV / AIDSPreclinical
Broad-Spectrum CandidatesEbola/MarburgPreclinical

Leadership Team at NanoViricides

MV
Meeta Vyas
Chief Financial Officer
RB
Randall Barton
Chief Scientific Officer
JT
Jayant Tatake
Vice President, R&D
MJ
Mak Jawadekar
Independent Board Member
View full NanoViricides profile